# Outset Medical signs $40M HCA Tablo hemodialysis system contract

Outset Medical entered into a Refresh Amendment with HCA Management Services for HCA to purchase new Tablo Hemodialysis Systems from 2026 through 2028, with an aggregate contract value of approximately $40 million.

- Type: Contract
- Announced: 2026-05-11
- Where: United States
- Value: $40.0M
- Status: announced
- Products: Tablo Hemodialysis Systems
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Outset Medical](https://endata.com/companies/55564.md)
- [HCA Management Services](https://endata.com/companies/91867.md) (customer)

## Sources

- [stocktitan.net](https://www.stocktitan.net/sec-filings/OM/8-k-outset-medical-inc-reports-material-event-cc226005fc51.html), 2026-05-11: "HCA plans to purchase new Tablo systems from 2026 through the end of 2028 for an aggregate contract value of approximately $40 million, net of rebates and allowances."
- [tradingview.com](https://www.tradingview.com/news/tradingview:1d08c86b2f8b2:0-outset-medical-wins-40-million-hca-fleet-refresh-for-tablo-systems-through-2028/), 2026-06-17: "The committed capital purchase totals approximately $40 million, net of rebates and allowances, with deliveries commencing in 2026 and continuing through the end of 2028."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.
